54 results
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
by the Research Department of the Bank of Israel, the Israeli growth rate in 2024 is expected to be 2% as well, and the rate of growth in private consumption … liability presented in the financial status report:
As for December 31
Benefits after employment termination by departments:
PDI department
Sales
6-K
EX-99.1
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
to 2022. In a forecast published in January 2024 by the Research Department of the Bank of Israel, the Israeli growth rate in 2024 is expected to be 2 … termination by departments:
PDI department
Sales department
Management
Note 21 - Contingent liabilities, engagements, encumbrances and guarantees
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
made by the Centers for Medicare & Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services, or DHHS, as CMS decides … for international operations. The U.S. Department of Justice and the SEC, which have responsibility for enforcement of the FCPA, both consider employees
6-K
EX-10.1
SPRC
SciSparc Ltd
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
. Department of Treasury’s Office of Foreign Asset Control (“OFAC”), the United Nations Security Council, the European Union, His Majesty’s Treasury
6-K
EX-4.1
5j2kh44vw5o9
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-1.1
3ji11pi89n71rxe
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
6-K
EX-99.2
sgvhi
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
6-K
EX-99.1
k187nb
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
6-K
EX-99.1
i3m2h3 1m
9 Aug 23
SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million
7:30pm
6-K
EX-99.1
dy7yqnn6l977e9
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
6-K
EX-99.1
3mhv76lt78 bq
4 Apr 23
SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
5:48pm
6-K
EX-99.3
ub8ix751eauqwlqi
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
63g641xwrymjcpgy
11 Aug 22
Current Report
4:05pm
6-K
EX-99.1
vdgn0eun5fhva1l
2 Jun 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.2
6pleefxcpbbrofxyyzt9
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.1
r2m63 7e6
6 Jan 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
j0quwk
29 Dec 21
SciSparc Provides Updates Upon Conclusion of 2021
5:12pm